It inhibits the intracellular cytokine signaling pathways known to be active in severe COVID-19 and reduces levels of IL-2, IL-6, IL-10, IFN-γ, and granulocyte–macrophage colony-stimulating factor (GM-CSF), some of which are important to the cytolytic T cell response. The gene discussed is IL6; the disease is COVID-19.